Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
McKesson
Johnson and Johnson
Merck
Express Scripts

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Breckenridge Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?

BRECKENRIDGE has fifty approved drugs.

There are three tentative approvals on BRECKENRIDGE drugs.

Drugs and US Patents for Breckenridge

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 204386-001 Dec 21, 2018 RX No Yes   Start Trial   Start Trial
Breckenridge Pharm OXCARBAZEPINE oxcarbazepine TABLET;ORAL 078069-003 Jan 11, 2008 AB RX No No   Start Trial   Start Trial
Breckenridge ALPRAZOLAM alprazolam TABLET;ORAL 207507-004 Jul 9, 2018 AB RX No No   Start Trial   Start Trial
Breckenridge MEGESTROL ACETATE megestrol acetate SUSPENSION;ORAL 204688-001 Dec 1, 2017 AB RX No No   Start Trial   Start Trial
Breckenridge METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET;ORAL 207587-003 Mar 3, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKesson
Harvard Business School
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.